Pharma giant Novartis sees shares jump after strong Q1 [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Shares were up more than 4% in Switzerland and more than 5% in pre-market activity in New York. The company also raised its fiscal 2024 outlook for growth in sales and core operating income. Further, Novartis said it plans to propose Giovanni Caforio as chair of the board of directors at its annual general meeting in 2025. The 12-year term of Joerg Reinhardt is set to end as scheduled in 2025, when he will retire and not be available for re-election. Novartis chief executive Vas Narasimhan said, "Novartis continued our strong momentum with both sales growth and core margin expansion in Q1. Our performance was broad-based, across all key growth brands and geographies, allowing us to raise guidance for the full year 2024." For fiscal 2024, the company now expects net sales to grow high-single to low double-digit, compared to previously expected mid-single-digit growth. Core operating income is now projected to grow low double-digit to mid-teens from earlier estimate of high
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Fragile X Syndrome Global Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]Yahoo! Finance
- UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion [Yahoo! Finance]Yahoo! Finance
- Novartis to buy Mariana Oncology for $1B upfront [Seeking Alpha]Seeking Alpha
- Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer [Yahoo! Finance]Yahoo! Finance
- The Global Market for Smart Inhalers, 2018-2023 and 2024-2033 - Novartis, AstraZeneca, GlaxoSmithKline, 3M Health Care, and Boehringer Ingelheim International Dominate the $1.62 Billion Industry [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/23/24 - Beat
NVS
Sec Filings
- 4/23/24 - Form 6-K
- 2/15/24 - Form S-8
- NVS's page on the SEC website